Boston Scientific Adds $2B in Debt

Luke Timmerman12/10/09

Boston Scientific, the giant medical device company, said today it has raised $2 billion in a debt financing. The Natick, MA-based company (NYSE: BSX) secured interest rates ranging between 4.5 percent and 7.38 percent on notes that have to be paid back between 2015 and 2040.

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @